Dra. ISABEL PORTERO
CEO/CTO & FOUNDER OF THE COMPANY.
Isabel is our CEO/CTO & founder of the company. MD PhD in Innovative Medicines, expert in Biomedical developments at both Biotech and Pharma Industry with a strong transversal experience across functions and Departments. Designed and leaded EMA-granted scientific plans and created & leaded several teams.
Biography
Dra. Isabel Portero, the founder of the company and currently the CEO, is a PhD in Medicine with a sound background in the biomedical field, who before founding Biohope acquired an extensive experience as Medical and R&D Director for different hospitals, foundations, universities and biomedical/pharma companies, some of them in the Big Pharma industry like Merck or Roche. With a strong medical vocation and an entrepreneurial spirit, she decided to run her own biomedical company by joining a multidisciplinary team of professionals, who together aim at providing solutions to the unsolved medical needs in organ transplantation, a field to which Dr. Isabel Portero has dedicated an important part of her career as medical
RICARDO BRAGE
BUSINESS DEVELOPMENT DIRECTOR
Biography
Ricardo , is an economist and has several MBAs from prestigious institutions such as the University of Houston, ESADE, and the University of Chicago. He has extensive experience in senior management positions in pharmaceutical companies such as Sanofi and Merck in the area of business development and institutional relations.
CARLO ZANOTTI
TECHNICAL AND PRODUCT DEVELOPMENT DIRECTOR
Biography
Carlo holds a Degree in Biological Science from the Autonomous University of Madrid and is specialized in biochemistry and molecular biology. He also holds a Master’s Degree in Healthcare and Pharmacy Business Administration. Carlo Zanotti has developed his professional career in the field of diagnostics for more than 17 years. During his career, Carlo has held different marketing positions in laboratory diagnostics and biotechnology companies such as Chiron Diagnostics, Bayer Diagnostics, and Miltenyi Biotec. Since 2004 he has held different product development positions for a new treatment based on the use of stem cells from adipose tissue, an inmmunoassay based test and a first in class Raman spectroscopy based IVD device.
Dra. TERESA DÍEZ
MEDICAL DIRECTOR
Biography
She holds a Medical Degree from Autonoma University and the speciality of Family Medicine in Hospital Ramon and Cajal, both in Madrid, Spain. She is also Magister Public Health by the Technische Universität in Berlin, Germany. Teresa has worked for some years in the clinical practice and has built up an extensive experience in management positions in pharmaceutical companies such as GSK, Pfizer, AstraZeneca and Merck in the area of Medical Affairs, at a local and international level.
FRANCISCO TEJERA
FINANCIAL DIRECTOR/ CFO
Economist with broad experience in the Pharma sector both in financial and quality areas.
Biography
Francisco Tejera, Economist (Universidad Complutense de Madrid), Project Manager Professional (PMI) and ITIL/ISO 20000 Practitioner certificate (APMG). Deep background in finance, SOX, tax law and GxP quality guidelines regulations. More than 20 years of experience as Chief Financial Officer in multinational environment. In particular in Information Tecnology and R&D companies as Bechtle; SIPEC & Makesoft.
Since 2011, external consultant as Information Technology Compliance Manager in different companies of The Spain Novartis Cluster for Production and Commercial activities including Sandoz Pharmaceutical & Alcón CusI (Novartis Companies).
GERARDO ENTRENA
LEGAL AFFAIRS DIRECTOR
Formerly Legal Director at several important companies in the tech/media sector.
Biography
Gerardo Entrena, our Legal Manager. Lawyer with a large experience of twenty-five years giving legal advice in Legal Firms and companies of regulated sectors, mainly telecommunications and energy,.His professional background enables to offer an overall strategic vision of companies, , outstandingly in civil matters and corporate matters, and solution of legal problems through Alternative Disputes Resolution and, if necessary, in High Courts.
